United States Healthcare Providers & Services

Neogenomics Inc (NEO)

Track

Recent insider activity at Neogenomics Inc. shows a net sell-off over the last 90 days, with one director proposing a sale. Prior to this, significant buying activity was observed from executives including the CEO and CFO in May and August 2025. The stock has seen a notable price increase of 43.4% in the last 90 days.
Stock chart
Ticker: NEO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
TETRAULT LYNN A.
1 sale — total 100,000 USD
Sale 9 Jun 2026
Value US$3,428,151.59 | Price 387.01 | Shares 83,063
Proposed sale 9 Jun 2026
Value US$4,457,149.40 | Price 433.01 | Shares 43,276
Sale 20 Jan 2026
Value US$276,681.87 | Price 12.50 | Shares 22,128
Proposed sale 20 Jan 2026
Value US$283,017.12 | Price 12.79 | Shares 22,128
Planned sale 25 Nov 2025
Value US$250,992.00 | Price 12.00 | Shares 20,916
Proposed sale 25 Nov 2025
Value US$138,611.79 | Price 11.61 | Shares 11,939
Planned sale 16 Oct 2025
Value US$49,180.00 | Price 10.00 | Shares 4,918
Proposed sale 16 Oct 2025
Value US$49,032.46 | Price 9.97 | Shares 4,918
Buy 6 Aug 2025
Value US$112,322.00 | Price 5.62 | Shares 20,000
Buy 6 Aug 2025
Value US$99,953.60 | Price 5.58 | Shares 17,900
Buy 27 May 2025
Value US$38,000.00 | Price 7.60 | Shares 5,000
Buy 12 May 2025
Value US$48,894.60 | Price 8.58 | Shares 5,700
Buy 9 May 2025
Value US$56,974.40 | Price 8.14 | Shares 7,000
Buy 7 May 2025
Value US$31,124.40 | Price 7.78 | Shares 4,000
Buy 6 May 2025
Value US$148,918.77 | Price 7.88 | Shares 18,900
Buy 5 May 2025
Value US$76,300.00 | Price 7.63 | Shares 10,000
Buy 5 May 2025
Value US$34,977.45 | Price 7.76 | Shares 4,510
Planned buy 2 May 2025
Value US$150,104.00 | Price 7.51 | Shares 20,000
Planned sale 15 Nov 2024
Value US$79,475.06 | Price 15.36 | Shares 5,175
Proposed sale 15 Nov 2024
Value US$81,713.25 | Price 15.79 | Shares 5,175
Planned sale 15 Aug 2024
Value US$16,695.43 | Price 16.05 | Shares 1,040
Proposed sale 15 Aug 2024
Value US$16,452.80 | Price 15.82 | Shares 1,040
Proposed sale 15 Aug 2024
Value US$133,242.88 | Price 15.95 | Shares 8,353
Proposed sale 28 May 2024
Value US$198,336.30 | Price 14.29 | Shares 13,882
Sale 15 May 2024
Value US$16,511.26 | Price 15.74 | Shares 1,049
Proposed sale 15 May 2024
Value US$16,154.60 | Price 15.40 | Shares 1,049
Sale 4 Mar 2024
Value US$97,578.69 | Price 15.97 | Shares 6,112
Proposed sale 4 Mar 2024
Value US$97,608.64 | Price 15.97 | Shares 6,112
Planned sale 15 Feb 2024
Value US$38,712.90 | Price 14.96 | Shares 2,587
Proposed sale 15 Feb 2024
Value US$38,546.30 | Price 14.90 | Shares 2,587
Planned sale 17 Nov 2023
Value US$49,082.91 | Price 18.39 | Shares 2,669
Proposed sale 17 Nov 2023
Value US$47,961.93 | Price 17.97 | Shares 2,669
Planned sale 7 Mar 2022
Value US$58,692.61 | Price 18.29 | Shares 3,209
Planned sale 21 Dec 2021
Value US$64,610.00 | Price 35.00 | Shares 1,846
Buy 6 Dec 2021
Value US$520,710.00 | Price 30.63 | Shares 17,000
Planned sale 26 Nov 2021
Value US$1,228,357.90 | Price 36.85 | Shares 33,334
Planned sale 24 Nov 2021
Value US$928,250.00 | Price 37.13 | Shares 25,000
Planned sale 24 Nov 2021
Value US$1,227,987.72 | Price 36.84 | Shares 33,333
Planned sale 23 Nov 2021
Value US$1,239,654.27 | Price 37.19 | Shares 33,333
Sale 8 Jun 2021
Value US$859,631.64 | Price 41.46 | Shares 20,734
Sale 3 Jun 2021
Value US$1,247,701.77 | Price 40.11 | Shares 31,107
Sale 2 Jun 2021
Value US$6,835,199.70 | Price 40.39 | Shares 169,230
Sale 14 Dec 2020
Value US$1,031,412.00 | Price 51.06 | Shares 20,200
Sale 14 Dec 2020
Value US$1,291,750.00 | Price 51.67 | Shares 25,000
Sale 11 Dec 2020
Value US$1,263,000.00 | Price 50.52 | Shares 25,000
Sale 11 Dec 2020
Value US$749,850.00 | Price 49.99 | Shares 15,000
Sale 10 Dec 2020
Value US$1,006,000.00 | Price 50.30 | Shares 20,000
Sale 7 Dec 2020
Value US$2,257,788.10 | Price 49.45 | Shares 45,658
Sale 4 Dec 2020
Value US$3,095,419.58 | Price 48.07 | Shares 64,394
Sale 4 Dec 2020
Value US$1,181,822.04 | Price 47.88 | Shares 24,683
Sale 3 Dec 2020
Value US$958,102.44 | Price 48.03 | Shares 19,948
Sale 2 Dec 2020
Value US$374,400.00 | Price 46.80 | Shares 8,000
Sale 25 Nov 2020
Value US$3,505,325.52 | Price 45.48 | Shares 77,074
Sale 24 Nov 2020
Value US$2,391,725.94 | Price 45.19 | Shares 52,926
Sale 16 Nov 2020
Value US$2,959,600.00 | Price 42.28 | Shares 70,000
Sale 16 Nov 2020
Value US$4,234,000.00 | Price 42.34 | Shares 100,000
Sale 13 Nov 2020
Value US$4,935,333.12 | Price 41.56 | Shares 118,752
Sale 12 Nov 2020
Value US$5,114,240.64 | Price 42.18 | Shares 121,248
Sale 10 Nov 2020
Value US$95,004.00 | Price 42.00 | Shares 2,262
Sale 24 Sep 2020
Value US$291,738.33 | Price 35.01 | Shares 8,333
Sale 22 Sep 2020
Value US$85,632.00 | Price 35.68 | Shares 2,400
Sale 10 Sep 2020
Value US$1,410,605.83 | Price 37.13 | Shares 37,991
Sale 9 Sep 2020
Value US$2,647,139.34 | Price 36.98 | Shares 71,583
Sale 8 Sep 2020
Value US$376,691.38 | Price 36.13 | Shares 10,426
Sale 6 Aug 2020
Value US$3,246,375.00 | Price 39.35 | Shares 82,500
Sale 3 Aug 2020
Value US$849,420.00 | Price 38.61 | Shares 22,000
Sale 3 Aug 2020
Value US$510,250.00 | Price 39.25 | Shares 13,000
Sale 30 Jul 2020
Value US$3,105,358.52 | Price 38.17 | Shares 81,356
Sale 4 Mar 2020
Value US$3,027,149.98 | Price 30.86 | Shares 98,093
Sale 2 Mar 2020
Value US$564,800.00 | Price 28.24 | Shares 20,000
Sale 2 Mar 2020
Value US$64,952.00 | Price 28.24 | Shares 2,300
Sale 2 Mar 2020
Value US$712,000.00 | Price 28.48 | Shares 25,000
Sale 2 Mar 2020
Value US$7,212,500.00 | Price 28.85 | Shares 250,000
Sale 10 Dec 2019
Value US$210,960.00 | Price 26.37 | Shares 8,000
Sale 21 Nov 2019
Value US$562,141.74 | Price 24.27 | Shares 23,162
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-11 2026-06-09 S Sale
2.6
TETRAULT LYNN A.
Non-Executive Director
83,063 +47.8%
387.01
US$3,428,152 		83,063 +47.8% 387.01 US$3,428,152
2026-06-09 2026-06-09 PrS Proposed sale
2.6
LYNN TETRAULT

Director

Non-Executive Director
43,276
433.01
US$4,457,149 		43,276 433.01 US$4,457,149
2026-01-21 2026-01-20 S Sale
2.9
Stone Warren

Pres & Chief Operating Officer

Officer
1,204 +38.8%
139.65
US$1,964,294 		1,204 +38.8% 139.65 US$1,964,294
2026-01-20 2026-01-20 PrS Proposed sale
2.9
WARREN STONE

Officer

Officer
22,128
12.79
US$283,017 		22,128 12.79 US$283,017
2025-11-28 2025-11-25 PlS Planned sale
1.8
Olivo Alicia C

EVP, GC & Business Development

Officer
20,916 -40.2%
12.00
US$250,992 		20,916 -40.2% 12.00 US$250,992
2025-11-25 2025-11-25 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
11,939
11.61
US$138,612 		11,939 11.61 US$138,612
2025-10-20 2025-10-16 PlS Planned sale
1.8
Olivo Alicia C

EVP, GC & Business Development

Officer
4,918 -10.3%
10.00
US$49,180 		4,918 -10.3% 10.00 US$49,180
2025-10-16 2025-10-16 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
4,918
9.97
US$49,032 		4,918 9.97 US$49,032
2025-08-06 2025-08-06 B Purchase
3.4
Sherman Jeffrey Scott

Chief Financial Officer

Officer
20,000 +11.9%
5.62
US$112,322 		20,000 +11.9% 5.62 US$112,322
2025-08-06 2025-08-06 B Purchase
3.1
Zook Anthony P.

Chief Executive Officer

Executive Director
17,900 +88.8%
5.58
US$99,954 		17,900 +88.8% 5.58 US$99,954
2025-05-28 2025-05-27 B Purchase
1.4
Kelly Michael Aaron
Non-Executive Director
5,000 +inf%
7.60
US$38,000 		5,000 +inf% 7.60 US$38,000
2025-05-13 2025-05-12 B Purchase
2.9
Stone Warren

Pres & Chief Operating Officer

Officer
5,700 +5.6%
8.58
US$48,895 		5,700 +5.6% 8.58 US$48,895
2025-05-09 2025-05-09 B Purchase
2.6
TETRAULT LYNN A.
Non-Executive Director
7,000 +inf%
8.14
US$56,974 		7,000 +inf% 8.14 US$56,974
2025-05-09 2025-05-07 B Purchase
1.4
KANOVSKY STEPHEN M
Non-Executive Director
4,000 +11.1%
7.78
US$31,124 		4,000 +11.1% 7.78 US$31,124
2025-05-08 2025-05-06 B Purchase
3.1
Zook Anthony P.

Chief Executive Officer

Executive Director
18,900 +inf%
7.88
US$148,919 		18,900 +inf% 7.88 US$148,919
2025-05-07 2025-05-05 B Purchase
1.5
Perez David Brian
Non-Executive Director
10,000 +inf%
7.63
US$76,300 		10,000 +inf% 7.63 US$76,300
2025-05-07 2025-05-05 B Purchase
1.5
Gunn Neil
Non-Executive Director
4,510 +39.8%
7.76
US$34,977 		4,510 +39.8% 7.76 US$34,977
2025-05-06 2025-05-02 PP Planned purchase
3.4
Sherman Jeffrey Scott

Chief Financial Officer

Officer
20,000 +14.4%
7.51
US$150,104 		20,000 +14.4% 7.51 US$150,104
2024-11-19 2024-11-15 PlS Planned sale
1.8
Olivo Alicia C

General Counsel

Officer
5,175 -12.2%
15.36
US$79,475 		5,175 -12.2% 15.36 US$79,475
2024-11-15 2024-11-15 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
5,175
15.79
US$81,713 		5,175 15.79 US$81,713
2024-08-19 2024-08-15 PlS Planned sale
1.8
Olivo Alicia C

General Counsel

Officer
1,040 -2.3%
16.05
US$16,695 		1,040 -2.3% 16.05 US$16,695
2024-08-15 2024-08-15 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
1,040
15.82
US$16,453 		1,040 15.82 US$16,453
2024-08-15 2024-08-15 PrS Proposed sale
1.7
BRUCE K CROWTHER

Officer; Director

Executive Director
8,353
15.95
US$133,243 		8,353 15.95 US$133,243
2024-05-28 2024-05-28 PrS Proposed sale
1.7
BRUCE K CROWTHER

Officer; Director

Executive Director
13,882
14.29
US$198,336 		13,882 14.29 US$198,336
2024-05-17 2024-05-15 S Sale
1.8
Olivo Alicia C

General Counsel

Officer
1,049 -2.3%
15.74
US$16,511 		1,049 -2.3% 15.74 US$16,511
2024-05-15 2024-05-15 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
1,049
15.40
US$16,155 		1,049 15.40 US$16,155
2024-03-06 2024-03-04 S Sale
2.6
TETRAULT LYNN A.
Non-Executive Director
6,112 -10.9%
15.97
US$97,579 		6,112 -10.9% 15.97 US$97,579
2024-03-04 2024-03-04 PrS Proposed sale
2.6
LYNN TETRAULT

Director

Non-Executive Director
6,112
15.97
US$97,609 		6,112 15.97 US$97,609
2024-02-20 2024-02-15 PlS Planned sale
1.8
Olivo Alicia C

General Counsel

Officer
2,587 -6.9%
14.96
US$38,713 		2,587 -6.9% 14.96 US$38,713
2024-02-15 2024-02-15 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
2,587
14.90
US$38,546 		2,587 14.90 US$38,546
2023-11-20 2023-11-17 PlS Planned sale
1.8
Olivo Alicia C

General Counsel

Officer
2,669 -6.7%
18.39
US$49,083 		2,669 -6.7% 18.39 US$49,083
2023-11-17 2023-11-17 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
2,669
17.97
US$47,962 		2,669 17.97 US$47,962
2022-03-09 2022-03-07 PlS Planned sale
2.0
Bonello William

Chief Financial Officer

Officer
3,209 -3.2%
18.29
US$58,693 		3,209 -3.2% 18.29 US$58,693
2021-12-23 2021-12-21 PlS Planned sale
McKenzie Kathryn B

Chief Financial Officer

Officer
1,846 -13.6%
35.00
US$64,610 		1,846 -13.6% 35.00 US$64,610
2021-12-06 2021-12-06 B Purchase
0.7
Mallon Mark

Chief Executive Officer

Executive Director
17,000 +30.5%
30.63
US$520,710 		17,000 +30.5% 30.63 US$520,710
2021-11-26 2021-11-26 PlS Planned sale
Brown Douglas Matthew

Chief Strategy Officer

Officer
33,334 -74.1%
36.85
US$1,228,358 		33,334 -74.1% 36.85 US$1,228,358
2021-11-29 2021-11-24 PlS Planned sale
2.0
Bonello William

President, Informatics

Officer
25,000 -61.8%
37.13
US$928,250 		25,000 -61.8% 37.13 US$928,250
2021-11-26 2021-11-24 PlS Planned sale
Brown Douglas Matthew

Chief Strategy Officer

Officer
33,333 -42.6%
36.84
US$1,227,988 		33,333 -42.6% 36.84 US$1,227,988
2021-11-26 2021-11-23 PlS Planned sale
Brown Douglas Matthew

Chief Strategy Officer

Officer
33,333 -29.9%
37.19
US$1,239,654 		33,333 -29.9% 37.19 US$1,239,654
2021-06-10 2021-06-08 S Sale
1.7
CROWTHER BRUCE K
Non-Executive Director
20,734 -29.5%
41.46
US$859,632 		20,734 -29.5% 41.46 US$859,632
2021-06-04 2021-06-03 S Sale
2.0
CARDOZA GEORGE

President, Pharma Services

Officer
31,107 -15.0%
40.11
US$1,247,702 		31,107 -15.0% 40.11 US$1,247,702
2021-06-04 2021-06-02 S Sale
2.0
CARDOZA GEORGE

President, Pharma Services

Officer
169,230 -44.9%
40.39
US$6,835,200 		169,230 -44.9% 40.39 US$6,835,200
2020-12-15 2020-12-14 S Sale
2.0
Weiss Lawrence Martin

Chief Medical Officer

Officer
20,200 -16.7%
51.06
US$1,031,412 		20,200 -16.7% 51.06 US$1,031,412
2020-12-14 2020-12-14 S Sale
2.6
JONES STEVEN C
Non-Executive Director
25,000 -2.4%
51.67
US$1,291,750 		25,000 -2.4% 51.67 US$1,291,750
2020-12-14 2020-12-11 S Sale
2.6
JONES STEVEN C
Non-Executive Director
25,000 -2.4%
50.52
US$1,263,000 		25,000 -2.4% 50.52 US$1,263,000
2020-12-11 2020-12-11 S Sale
2.3
BALLIET JENNIFER

VP and Chief Culture Officer

Officer
15,000 -37.5%
49.99
US$749,850 		15,000 -37.5% 49.99 US$749,850
2020-12-14 2020-12-10 S Sale
2.6
JONES STEVEN C
Non-Executive Director
20,000 -1.9%
50.30
US$1,006,000 		20,000 -1.9% 50.30 US$1,006,000
2020-12-07 2020-12-07 S Sale
2.6
JONES STEVEN C
Non-Executive Director
45,658 -4.1%
49.45
US$2,257,788 		45,658 -4.1% 49.45 US$2,257,788
2020-12-07 2020-12-04 S Sale
2.6
JONES STEVEN C
Non-Executive Director
64,394 -5.5%
48.07
US$3,095,420 		64,394 -5.5% 48.07 US$3,095,420
2020-12-07 2020-12-04 S Sale
1.5
Johnson Kevin C
Non-Executive Director
24,683 -44.3%
47.88
US$1,181,822 		24,683 -44.3% 47.88 US$1,181,822
2020-12-07 2020-12-03 S Sale
2.6
JONES STEVEN C
Non-Executive Director
19,948 -1.7%
48.03
US$958,102 		19,948 -1.7% 48.03 US$958,102
2020-12-04 2020-12-02 S Sale
2.0
Bonello William

President, Informatics

Officer
8,000 -39.9%
46.80
US$374,400 		8,000 -39.9% 46.80 US$374,400
2020-11-25 2020-11-25 S Sale
2.0
CARDOZA GEORGE

President, Pharma Services

Officer
77,074 -17.2%
45.48
US$3,505,326 		77,074 -17.2% 45.48 US$3,505,326
2020-11-25 2020-11-24 S Sale
2.0
CARDOZA GEORGE

President, Pharma Services

Officer
52,926 -12.5%
45.19
US$2,391,726 		52,926 -12.5% 45.19 US$2,391,726
2020-11-18 2020-11-16 S Sale
1.4
HIPP RAYMOND R
Non-Executive Director
70,000 -51.2%
42.28
US$2,959,600 		70,000 -51.2% 42.28 US$2,959,600
2020-11-16 2020-11-16 S Sale
0.9
VAN OORT DOUGLAS M

Chairman and CEO

Executive Director
100,000 -4.0%
42.34
US$4,234,000 		100,000 -4.0% 42.34 US$4,234,000
2020-11-16 2020-11-13 S Sale
0.9
VAN OORT DOUGLAS M

Chairman and CEO

Executive Director
118,752 -4.5%
41.56
US$4,935,333 		118,752 -4.5% 41.56 US$4,935,333
2020-11-16 2020-11-12 S Sale
0.9
VAN OORT DOUGLAS M

Chairman and CEO

Executive Director
121,248 -5.1%
42.18
US$5,114,241 		121,248 -5.1% 42.18 US$5,114,241
2020-11-12 2020-11-10 S Sale
0.6
Pedulla Denise E

General Counsel

Officer
2,262 -3.8%
42.00
US$95,004 		2,262 -3.8% 42.00 US$95,004
2020-09-24 2020-09-24 S Sale
1.7
CROWTHER BRUCE K
Non-Executive Director
8,333 -15.2%
35.01
US$291,738 		8,333 -15.2% 35.01 US$291,738
2020-09-24 2020-09-22 S Sale
1.7
CROWTHER BRUCE K
Non-Executive Director
2,400 -4.9%
35.68
US$85,632 		2,400 -4.9% 35.68 US$85,632
2020-09-10 2020-09-10 S Sale
2.6
JONES STEVEN C
Non-Executive Director
37,991 -2.7%
37.13
US$1,410,606 		37,991 -2.7% 37.13 US$1,410,606
2020-09-10 2020-09-09 S Sale
2.6
JONES STEVEN C
Non-Executive Director
71,583 -4.8%
36.98
US$2,647,139 		71,583 -4.8% 36.98 US$2,647,139
2020-09-10 2020-09-08 S Sale
2.6
JONES STEVEN C
Non-Executive Director
10,426 -0.7%
36.13
US$376,691 		10,426 -0.7% 36.13 US$376,691
2020-08-10 2020-08-06 S Sale
2.0
CARDOZA GEORGE

President, Pharma Services

Officer
82,500 -19.0%
39.35
US$3,246,375 		82,500 -19.0% 39.35 US$3,246,375
2020-08-04 2020-08-03 S Sale
2.0
Bonello William

President, Informatics

Officer
22,000 -64.6%
38.61
US$849,420 		22,000 -64.6% 38.61 US$849,420
2020-08-04 2020-08-03 S Sale
2.3
BALLIET JENNIFER

VP and Chief Culture Officer

Officer
13,000 -34.2%
39.25
US$510,250 		13,000 -34.2% 39.25 US$510,250
2020-08-03 2020-07-30 S Sale
2.4
SHOVLIN ROBERT J.

President, Clinical Services

Officer
81,356 -35.4%
38.17
US$3,105,359 		81,356 -35.4% 38.17 US$3,105,359
2020-03-05 2020-03-04 S Sale
2.4
SHOVLIN ROBERT J.

President, Clinical Services

Officer
98,093 -39.3%
30.86
US$3,027,150 		98,093 -39.3% 30.86 US$3,027,150
2020-03-04 2020-03-02 S Sale
2.6
JONES STEVEN C
Non-Executive Director
20,000 -39.6%
28.24
US$564,800 		20,000 -39.6% 28.24 US$564,800
2020-03-04 2020-03-02 S Sale
2.6
JONES STEVEN C
Non-Executive Director
2,300 -5.3%
28.24
US$64,952 		2,300 -5.3% 28.24 US$64,952
2020-03-04 2020-03-02 S Sale
2.6
JONES STEVEN C
Non-Executive Director
25,000 -16.7%
28.48
US$712,000 		25,000 -16.7% 28.48 US$712,000
2020-03-04 2020-03-02 S Sale
2.6
JONES STEVEN C
Non-Executive Director
250,000 -15.4%
28.85
US$7,212,500 		250,000 -15.4% 28.85 US$7,212,500
2019-12-12 2019-12-10 S Sale McKenzie Kathryn B

Chief Accounting Officer

Officer
8,000 -77.9%
26.37
US$210,960 		8,000 -77.9% 26.37 US$210,960
2019-11-22 2019-11-21 S Sale JONES STEVEN C Non-Executive Director
23,162 -1.5%
24.27
US$562,142 		23,162 -1.5% 24.27 US$562,142
Explore more

More insider trading research around Neogenomics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America